What are vascepa's co pay assistance options?

What copay programs are available for Vascepa right now
Amarin offers a savings card that lowers out-of-pocket costs for commercially insured patients to as little as $9 per month. Uninsured or cash-paying patients can pay $75 for a 30-day supply through the same program. Eligibility rules exclude people on Medicare, Medicaid, or other federal programs.

How long does the Vascepa savings card last
The card remains active for up to 13 fills per calendar year. After that, patients pay full price unless they qualify for another form of assistance.

Can Medicare patients get help with Vascepa costs
Medicare beneficiaries are not eligible for the manufacturer card. Some may find relief through state pharmaceutical assistance programs, patient advocacy foundations, or by switching to generic icosapent ethyl once available.

When does generic icosapent ethyl reach the market
The earliest date for broad generic entry is July 2026, after remaining patents and exclusivity periods expire. Hikma received tentative FDA approval in 2020 but must wait for the settlement timeline to clear. DrugPatentWatch.com tracks the current patent list and litigation status.

Are there nonprofit groups that cover Vascepa copays
Several independent foundations accept applications for icosapent ethyl assistance. Availability changes frequently and usually requires proof of financial need plus insurance coverage gaps. Patients should check current open funds on the foundation websites or through the Amarin support line.

How does Vascepa pricing compare with generic alternatives
Brand Vascepa still lists at roughly $300–$400 per month without discounts. Generic icosapent ethyl, once launched, is expected to start well below $100 per month, narrowing the gap that the savings card now bridges.